Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry.
Jerry W CallYu WangDenisse MontoyaNorman J ScherzerMichael C HeinrichPublished in: Clinical sarcoma research (2019)
[This corrects the article DOI: 10.1186/s13569-019-0114-5.].
Keyphrases